News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Avant Immunotherapeutics (AVAN) CEO to Present at the Needham & Company Biotechnology & Medical Technology Conference



6/4/2008 10:01:23 AM

NEEDHAM, Mass.--(BUSINESS WIRE)--AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) today announced that Anthony S. Marucci, Interim President and Chief Executive Officer of AVANT Immunotherapeutics, Inc., will present at the Seventh Annual Needham & Company, LLC Biotechnology & Medical Technology Conference at the New York Palace Hotel in New York City on Wednesday, June 11 at 11:30 am, EDT.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES